Atlas Trials

Compared the Efficacy and Safety of CDOP Combined With Chidamide and CDOP in de Novo Peripheral T Cell Lymphoma Patients

Clinical trial NCT03023358 · UNKNOWN

Trial details

NCT number
NCT03023358
Sponsor
Nanfang Hospital, Southern Medical University
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Peripheral T Cell Lymphoma
Start date
2017-02-01
Primary completion
2019-03-01
Enrollment
174

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.